BCA
INO icon

Bay Colony Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Bay Colony Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,688
Closed -$70K – 212
2019
Q4 		$70K Buy
1,688
+563
+50% +$16.9K 0.05% 257
2019
Q3 		$28K Hold
1,125
– – 0.02% 248
2019
Q2 		$40K Buy
+1,125
New +$44.7K 0.03% 210

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Bay Colony Advisors's INO Position: Q1 2020 in Review

Bay Colony Advisors sold out of Inovio Pharmaceuticals (INO) in Q1 2020, closing a stake of 1,688 shares — an estimated $70K sold.

Bay Colony Advisors first reported a position in INO in Q2 2019 and held it in 3 quarters. The position peaked at $70K in Q4 2019. 158 funds tracked by Wall St. Rank hold INO as of Q1 2020.

  • Bay Colony Advisors reported no remaining Inovio Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Bay Colony Advisors sold 1,688 Inovio Pharmaceuticals shares in Q1 2020, an estimated $70K.
  • Bay Colony Advisors first reported a position in Inovio Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Bay Colony Advisors's Inovio Pharmaceuticals position peaked at $70K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2020.

Based on Bay Colony Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.